Michael Keeney
Overview
Explore the profile of Michael Keeney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegel D, Hui H, Pitts J, Vermillion M, Ishida K, Rautiola D, et al.
J Med Chem
. 2024 Jul;
67(15):12945-12968.
PMID: 39018526
Acute respiratory viral infections, such as pneumovirus and respiratory picornavirus infections, exacerbate disease in COPD and asthma patients. A research program targeting respiratory syncytial virus (RSV) led to the discovery...
2.
Keeney M, Keeney G, Cheville J, Gupta S
Hum Pathol
. 2024 Jun;
151:105617.
PMID: 38914169
No abstract available.
3.
Borowitz M, Wood B, Keeney M, Hedley B
Curr Protoc
. 2022 Mar;
2(3):e383.
PMID: 35263042
Measurable (minimal) residual disease (MRD) in B-acute lymphoblastic leukemia (B-ALL), as assessed by flow cytometry, is an established prognostic factor used to adjust treatment in most pediatric therapeutic protocols. MRD...
4.
Deveza L, Ashoken J, Castaneda G, Tong X, Keeney M, Han L, et al.
ACS Biomater Sci Eng
. 2021 Jan;
1(3):157-165.
PMID: 33429514
Polymeric microspheres represent an injectable platform for controlling the release of a variety of biologics; microspheres may be combined in a modular fashion to achieve temporal release of two or...
5.
Lowes L, Hedley B, Sutherland D, Keeney M
Cytometry B Clin Cytom
. 2020 Oct;
100(4):402-405.
PMID: 33009886
No abstract available.
6.
Hupp M, Bashleben C, Cardinali J, Dorfman D, Karlon W, Keeney M, et al.
Arch Pathol Lab Med
. 2020 Sep;
145(3):336-342.
PMID: 32886757
Context.—: Minimal residual disease (MRD) testing by flow cytometry is ubiquitous in hematolymphoid neoplasm monitoring, especially B-lymphoblastic leukemia (B-ALL), for which it provides predictive information and guides management. Major heterogeneity...
7.
Hedley B, Cheng G, Keeney M, Kern W, Padurean A, Luider J, et al.
Cytometry B Clin Cytom
. 2020 Jul;
100(2):225-234.
PMID: 32667744
Multiparameter flow cytometry plays an important role in the diagnosis, staging, and monitoring of patients with a suspected hematological malignancy. The ClearLLab 10C Panels consist of four reagent panels (B-Lineage...
8.
Cherian S, Hedley B, Keeney M
Cytometry B Clin Cytom
. 2019 Nov;
96(6):449-463.
PMID: 31697047
Flow cytometry (FC) has proven to be an extremely versatile and useful tool in the diagnosis and monitoring of hematological diseases in addition to numerous other applications. Major advances in...
9.
Russell S, Sholzberg M, Mangel J, Keeney M, Hedley B, Bode M, et al.
Int J Lab Hematol
. 2018 Dec;
41(3):e66-e69.
PMID: 30512241
No abstract available.
10.
Sutherland D, Illingworth A, Marinov I, Ortiz F, Andreasen J, Payne D, et al.
Cytometry B Clin Cytom
. 2017 Dec;
94(1):23-48.
PMID: 29236353
Since publication in 2010 of the International Clinical Cytometry Society (ICCS) Consensus Guidelines for detection of Paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometery, a great deal of work has been...